Long-Term Safety and Efficacy of 4-Weekly Certolizumab Pegol Combination and Monotherapy in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension Study

被引：0
|
作者：
Fleischmann, Roy M. [1 ]
van Vollenhoven, Ronald F. [2 ]
Vencovsky, Jiri [3 ]
Alten, Rieke [4 ]
Davies, Owen [5 ]
Stach, Christian [6 ]
de Longueville, Marc [5 ]
Van Lunen, Brenda [7 ]
Choy, Ernest [8 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[2] Karolinska Inst, Stockholm, Sweden
[3] Inst Rheumatol, Prague, Czech Republic
[4] Univ Med Berlin, Schlosspk Klin, Berlin, Germany
[5] UCB Pharma, Brussels, Belgium
[6] UCB Pharma, Monheim, Germany
[7] UCB Pharma, Raleigh, NC USA
[8] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1316
引用
收藏
页码：S565 / S566
页数：2
相关论文
共 50 条
  • [11] Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 24-Week Randomized Controlled Trial and Open-Label Extension Study
    Smolen, Josef S.
    van Vollenhoven, Ronald
    Kavanaugh, Arthur
    Strand, Vibeke
    Vencovsky, Jiri
    Schiff, Michael H.
    Landewe, Robert
    Haraoui, Boulos
    Walker, Susan
    van der Heijde, Desiree
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S988 - S989
  • [12] Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 52-Week Randomized Controlled Trial and Open-Label Extension Study
    Keystone, Edward
    Landewe, Robert
    van Vollenhoven, Ronald
    Combe, Bernard
    Strand, Vibeke
    Mease, Philip J.
    Shaughnessy, Laura
    VanLunen, Brenda
    van der Heijde, Desiree
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S596 - S597
  • [13] LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN COMBINATION WITH METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM A 52-WEEK RANDOMIZED CONTROLLED TRIAL AND OPEN-LABEL EXTENSION STUDY
    Keystone, Edward
    Landewe, Robert
    van Vollenhoven, Ronald
    Combe, Bernard
    Strand, Vibeke
    Mease, Philip J.
    Shaughnessy, Laura
    vanlunen, Brenda
    van der Heijde, Desiree
    [J]. RHEUMATOLOGY, 2014, 53 : 96 - 96
  • [14] Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 52-Week Randomized Controlled Trial and Open-Label Extension Study
    Keystone, Edward
    Landewe, Robert
    van Vollenhoven, Ronald
    Combe, Bernard
    Strand, Vibeke
    Mease, Phillip
    Shaughnessy, Laura
    VanLunen, Brenda
    van der Heijde, Desiree
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1455 - 1456
  • [15] Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 24-Week Randomized Controlled Trial and Open-Label Extension Study
    Smolen, Josef
    Van Vollenhoven, Ronald
    Kavanaugh, Arthur
    Strand, Vibeke
    Vencovsky, Jiri
    Schiff, Michael
    Landewe, Robert
    Haraoui, Boulos
    Walker, Susan
    van der Heijde, Desiree
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1506 - 1507
  • [16] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
    Feist, Eugen
    Nasonov, Evgeny
    Luggen, Michael
    Fatenejad, Saeed
    Grishin, Sergey
    Samsonov, Mikhail
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
  • [17] Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients who could not receive methotrexate: 52-week results from an open-label extension of the HIKARI study
    Tanaka, Yoshiya
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Shoji, Toshiharu
    Miyasaka, Nobuyuki
    Koike, Takao
    [J]. MODERN RHEUMATOLOGY, 2014, 24 (05) : 725 - 733
  • [18] Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: 52-week results from an open-label extension of the J-RAPID study
    Tanaka, Yoshiya
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Shoji, Toshiharu
    Miyasaka, Nobuyuki
    Koike, Takao
    [J]. MODERN RHEUMATOLOGY, 2014, 24 (05) : 734 - 743
  • [19] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
    Alan Kivitz
    Alvin F. Wells
    Juan I. Vargas
    Herbert S. B. Baraf
    Maureen Rischmueller
    Justin Klaff
    Nasser Khan
    Yihan Li
    Kyle Carter
    Alan Friedman
    Patrick Durez
    [J]. Rheumatology and Therapy, 2023, 10 : 901 - 915
  • [20] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY
    Kivitz, Alan
    Wells, Alvin F.
    Vargas, Juan I.
    Baraf, Herbert S. B.
    Rischmueller, Maureen
    Klaff, Justin
    Khan, Nasser
    Li, Yihan
    Carter, Kyle
    Friedman, Alan
    Durez, Patrick
    [J]. RHEUMATOLOGY, 2023, 62
12345